U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864988) titled '4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration' on March 04.
Brief Summary: A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Macular Neovascularization Secondary to Age-Related Macular Degeneration
Intervention:
BIOLOGICAL: 4D-150 IVT (3E10 vg/eye)
If randomized to the 4D-150 treatment arm, 4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1
BIOLOGICAL: EYLEA(R) (afliber...